$VTEX

VTEX

Insider trades

No enriched coverage for $VTEX in the last 7 days.

$185K
Gomide de Faria Mariano
100%
See all $VTEX insider activity →

VTEX sentiment & insider activity

Recent VTEX coverage spans insider activity and financial news.

In the last 30 days, VTEX insiders filed 10 SEC Form 4 transactions — no purchases and 10 sales ($185K). The most active reporter was Gomide de Faria Mariano, Chief Executive Officer, with 4 filings. 100% of activity was filed under pre-arranged Rule 10b5-1 plans.

What's driving VTEX

  • Insider selling can modestly affect near-term sentiment, but this single Form 4 (no 10b5-1 plan stated) is not a fundamental catalyst by itself.

    SEC EDGAR · Jun 3, 2026

  • Insider open-market selling by the CEO is typically a low-to-moderate signal; without a 10b5-1 plan, it can raise near-term attention but lacks fundamental new information.

    SEC EDGAR · Jun 3, 2026

  • Insider selling is a modest, non-fundamental signal; it may slightly affect sentiment but lacks evidence of a new business catalyst.

    SEC EDGAR · Jun 3, 2026

  • Insider selling is disclosed, but the filing provides no new fundamental catalyst; it mainly informs sentiment/positioning.

    SEC EDGAR · Jun 3, 2026

  • Insider selling via 10b5-1 is typically low-signal; it may slightly affect sentiment but is unlikely to change fundamentals by itself.

    SEC EDGAR · Jun 3, 2026

alphai scores every news story that mentions VTEX with an AI model for sentiment and relevance, and aggregates insider trades from VTEX's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $VTEX

Score
$VTEXLow

VTEX (VTEX) CSO sells 3,000 shares under Rule 10b5-1 plan

VTEX's Chief Strategy Officer, Gomes Andre Spolidoro Ferreira, reported routine insider sales of 3,000 Class A Common Shares on May 18, 2026, at $3.51 per share. These transactions, split between indirect and direct holdings, were conducted under a pre-arranged Rule 10b5-1 Trading Plan adopted in February 2025. After the sales, Ferreira holds 312,029 direct shares and 42,400 indirect shares through Botsmark LLC.

$VTEXMed

VTEX (NYSE: VTEX) CEO sells 4,808 shares under 10b5-1 plan

VTEX CEO Geraldo do Carmo Thomaz Junior reported selling 4,808 Class A Common Shares at a weighted average price of $4.04 per share on April 6, 2026. This sale was executed under a pre-arranged Rule 10b5-1 Trading Plan adopted in October 2025. Following the transaction, the CEO retains significant direct and indirect holdings in the company.

Related tickers